| Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma C Sun, A Mahendravada, B Ballard, B Kale, C Ramos, J West, T Maguire, ... Oncotarget 10 (24), 2369, 2019 | 84 | 2019 |
| BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT SN Copsel, CO Lightbourn, H Barreras, I Lohse, D Wolf, CS Bader, ... Frontiers in immunology 9, 3104, 2019 | 21 | 2019 |
| Very Low Numbers of CD4+ FoxP3+ Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model S Copsel, D Wolf, B Kale, H Barreras, CO Lightbourn, CS Bader, ... Biology of Blood and Marrow Transplantation 24 (9), 1788-1794, 2018 | 21 | 2018 |
| IL-2/IL-2R, TL1A/TNFRSF25 or Their Combined Stimulation Results in Distinct CD4+ FoxP3+ Regulatory T Cell Phenotype and Suppressive Function SN Copsel, H Barreras, CO Lightbourn, CS Bader, D Wolf, B Kale, ... Biology of Blood and Marrow Transplantation 26 (3), S169, 2020 | 4 | 2020 |
| Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia BJ Kale, NR Wilson, N Pemmaraju Manual of Hematopoietic Cell Transplantation and Cellular Therapies, 205-216, 2023 | | 2023 |
| A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia BJ Kale, G Hwang, PS Teegavarapu, MP Mims, G Rivero Blood 140 (Supplement 1), 8934-8935, 2022 | | 2022 |
| Multiple Pathways Targeting CD25 or TNFRSF25 Affect CD4+FoxP3+ Regulatory T Cell Phenotype and Suppressive Function SN Copsel, H Barreras, CO Lightbourn, CS Bader, D Wolf, B Kale, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Identification of a BET Bromodomain Inhibitor That Enables Treg Function: A Combinatorial Strategy to Inhibit GVHD S Copsel, CO Lightbourn, H Barreras, I Lohse, D Wolf, CS Bader, J Manov, ... Biology of Blood and Marrow Transplantation 25 (3), S25-S26, 2019 | | 2019 |
| Development of a Concomitant Treg Expansion and Stem Cell Mobilization Protocol Which Enables Peripheral Blood Transplant Amelioration of Gvhd Following Pre-Clinical aHSCT H Barreras, CS Bader, S Copsel, B Kale, BJ Pfeiffer, C Lozano, ... Biology of Blood and Marrow Transplantation 25 (3), S292, 2019 | | 2019 |
| Sequential Cyclophosphamide and Trametinib Improve Clinical Graft Versus Host Disease and Survival in Murine Hematopoietic Stem Cell Transplant G Nahas, H Barreras, CS Bader, S Copsel, D Wolf, B Kale, RB Levy, ... Biology of Blood and Marrow Transplantation 25 (3), S296-S297, 2019 | | 2019 |
| Extremely Low Numbers of Donor Expanded Regulatory T Cells Characterized by Expression of an Activated Phenotype Can Suppress Graft-Versus-Host Disease S Copsel, D Wolf, B Kale, H Barreras, CO Lightbourn, CS Bader, ... Biology of Blood and Marrow Transplantation 24 (3), S170, 2018 | | 2018 |
| Regulatory T Cells Expanded Via TL1A-Ig Fusion Protein and Low Dose IL-2 Demonstrate Potent Suppression of Graft-Versus-Host Disease S Copsel, D Wolf, B Kale, H Barreras, CO Lightbourn, CS Bader, ... Blood 130 (Supplement 1), 4434-4434, 2017 | | 2017 |
